Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
BARD1 Life Sciences is a healthcare business based in Australia. BARD1 Life Sciences shares (BD1) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. BARD1 Life Sciences has a trailing 12-month revenue of around $1.3 million. If you're looking to buy shares, check out the steps below.
How to buy shares in BARD1 Life Sciences
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for BARD1 Life Sciences. Find the share by name or ticker symbol: BD1. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until BARD1 Life Sciences reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of BARD1 Life Sciences. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
What's in this guide?
- BARD1 Life Sciences key stats
- Compare share trading platforms
- Is BARD1 Life Sciences stock a buy or sell?
- BARD1 Life Sciences performance over time
- BARD1 Life Sciences's financials
- How volatile are BARD1 Life Sciences shares?
- Does BARD1 Life Sciences pay a dividend?
- Have BARD1 Life Sciences shares ever split?
- Other common questions
BARD1 Life Sciences stock price (ASX:BD1)
Use our graph to track the performance of BD1 stocks over time.BARD1 Life Sciences shares at a glance
Information last updated 2022-02-08.
| 52-week range | $0.95 - $2.07 |
|---|---|
| 50-day moving average | $1.0759 |
| 200-day moving average | $1.8735 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.144 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 9 of 9
Is it a good time to buy BARD1 Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
BARD1 Life Sciences price performance over time
Historical closes compared with the last close of A$1.04
| 6 months (2021-12-30) | -12.61% |
|---|
| 1 year (2021-06-30) | -44.68% |
|---|---|
| 2 years (2020-06-30) | -95.72% |
| 3 years (2019-06-28) | -96.02% |
| 5 years (2017-06-29) | -86.76% |
BARD1 Life Sciences financials
| Revenue TTM | $1.3 million |
|---|---|
| Gross profit TTM | $-499,407 |
| Return on assets TTM | -19.8% |
| Return on equity TTM | -62.77% |
| Profit margin | 0% |
| Book value | 0.363 |
| Market capitalisation | $95.2 million |
TTM: trailing 12 months
BARD1 Life Sciences share dividends
We're not expecting BARD1 Life Sciences to pay a dividend over the next 12 months.
Have BARD1 Life Sciences's shares ever split?
BARD1 Life Sciences's shares were split on a 1:30 basis on 1 December 2020. So if you had owned 30 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your BARD1 Life Sciences shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for BARD1 Life Sciences shares which in turn could have impacted BARD1 Life Sciences's share price.
BARD1 Life Sciences share price volatility
Over the last 12 months, BARD1 Life Sciences's shares have ranged in value from as little as $0.95 up to $2.07. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while BARD1 Life Sciences's is -0.6442. This would suggest that BARD1 Life Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, BARD1 Life Sciences has bucked the trend.
BARD1 Life Sciences overview
BARD1 Life Sciences Limited engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia.
BARD1 Life Sciences in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
-
How to buy Besra Gold (BEZ) shares
Steps to owning and managing Besra Gold shares.
-
How to buy The Lottery Corporation (TLC) shares
Steps to owning and managing The Lottery Corporation shares.
Ask an Expert
